InvestSMART

ImpediMed Limited (ASX: IPD) - Announcements

Current share price for IPD : $0.005 0.001 (16.67%)+

ASX company news and announcements for ImpediMed Limited (IPD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ImpediMed Limited (IPD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ImpediMed Limited (IPD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ImpediMed Limited (IPD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Appendix 4C - quarterly 31 Jan 2011 8:35AM $0.730 $0.005 fallen by 99.32%
$18 Share Purchase Plan Underwriting 7 Dec 2010 12:21PM $0.770 $0.005 fallen by 99.35%
$18 ImpediMed successfully completes Institutional Placement 3 Dec 2010 11:48AM $0.750 $0.005 fallen by 99.33%
$18 Trading Halt 2 Dec 2010 8:55AM $0.820 $0.005 fallen by 99.39%
$18 Key US medical group adopts L-Dex 24 Nov 2010 10:19AM $0.850 $0.005 fallen by 99.41%
$18 Appendix 4C - quarterly 28 Oct 2010 5:59PM $0.850 $0.005 fallen by 99.41%
$18 Another Managed Care Contract 30 Aug 2010 8:26AM $0.750 $0.005 fallen by 99.33%
$18 Appendix 4E Year Ended 30 June 2010 27 Aug 2010 3:16PM $0.775 $0.005 fallen by 99.35%
$18 First Managed Care Contract 25 Aug 2010 8:27AM $0.700 $0.005 fallen by 99.29%
$18 Appendix 4C - quarterly 30 Jul 2010 8:32AM $0.700 $0.005 fallen by 99.29%
$18 ImpediMed strengthens reimbursement position in the US 25 Jun 2010 9:29AM $0.580 $0.005 fallen by 99.14%
$18 Entitlement Offer Results 12 May 2010 8:26AM $0.645 $0.005 fallen by 99.22%
$18 US Grant Awarded Support Standard of Care using IPD Device 30 Apr 2010 9:14AM $0.700 $0.005 fallen by 99.29%
$18 Appendix 4C - quarterly 29 Apr 2010 1:01PM $0.650 $0.005 fallen by 99.23%
$18 Non-Renounceable Entitlement Offer 19 Apr 2010 11:35AM $0.690 $0.005 fallen by 99.28%
$18 ImpediMed Announces FDA Leg Claim Filed 7 Apr 2010 8:27AM $0.665 $0.005 fallen by 99.25%
$18 Placement and entitlement offer to raise up to $20.1 million 1 Apr 2010 12:20PM $0.800 $0.005 fallen by 99.38%
$18 United States Reimbursement Coding 8 Mar 2010 10:08AM $0.800 $0.005 fallen by 99.38%
$18 Trading Halt 5 Mar 2010 12:24PM $0.730 $0.005 fallen by 99.32%
$18 31 December 2009 Half Year Results Appendix 4D 24 Feb 2010 3:22PM $0.750 $0.005 fallen by 99.33%
$18 Appendix 4C - quarterly 29 Jan 2010 4:38PM $0.720 $0.005 fallen by 99.31%
$18 Appointment of Chinese Distributor 15 Dec 2009 8:38AM $0.820 $0.005 fallen by 99.39%
$18 Xitron Matter 15 Dec 2009 8:35AM $0.820 $0.005 fallen by 99.39%
$18 University Study supports ImpediMed Device 24 Nov 2009 10:12AM $0.810 $0.005 fallen by 99.38%
$18 American Medical Association Category 1 CPT Filing 12 Nov 2009 9:47AM $0.720 $0.005 fallen by 99.31%

1151 - 1175 of 1207 results

Page 47 of 49

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.